ORBIMED ADVISORS LLC Insider Trading $ROKA Sorrento Tech, Inc.
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in GLAUKOS Corp ($GKOS) and Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and in ACCELERON PHARMA INC ($XLRN) and Director in ProNAi Therapeutics Inc ($DNAI) and 10% Owner in AVEDRO INC ($AVDR) and 10% Owner in Relypsa Inc ($RLYP) and 10% Owner in Aerpio Pharmaceuticals, Inc. ($ARPO) and Director in Aerpio Pharmaceuticals, Inc. ($ZETAII) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in SELECTA BIOSCIENCES INC ($SELB) and Director in SI-BONE, Inc. ($SIBN) and Director in Xtant Medical Holdings, Inc. ($XTNT) and 10% Owner in Roka BioScience, Inc. ($ROKA) and Director in Roka BioScience, Inc. ($ROKA) and 10% Owner in Kala Pharmaceuticals, Inc. ($KALA) and Director in Otonomy, Inc. ($OTIC) and 10% Owner in Arsanis, Inc. ($ASNS) and 10% Owner in Principia Biopharma Inc. ($PRNB) and Director in Acutus Medical, Inc. ($AFIB) and Director in SYNLOGIC, INC. ($MIRN) and 10% Owner in NeuroPace Inc ($NPCE) and 10% Owner in GRAYBUG VISION, INC. ($GRAY) and 10% Owner in Sientra, Inc. ($SIEN) and 10% Owner in TELA Bio, Inc. ($TELA) and Director in Loxo Oncology, Inc. ($LOXO) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in Dimension Therapeutics, Inc. ($DMTX) and 10% Owner in Guardant Health, Inc. ($GH) and 10% Owner in ViewRay, Inc. ($VRAY) and Director in ViewRay, Inc. ($VRAY) and Director in Turning Point Therapeutics, Inc. ($TPTX) and in Tricida, Inc. ($TCDA) and Director in Tricida, Inc. ($TCDA) and 10% Owner in Inspire Medical Systems, Inc. ($INSP) and Director in Inspire Medical Systems, Inc. ($INSP) and Director in Synthorx, Inc. ($THOR) and 10% Owner in scPharmaceuticals Inc. ($SCPH) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and Director in Corvus Pharmaceuticals, Inc. ($CRVS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and Director in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and Director in Intellia Therapeutics, Inc. ($NTLA) and 10% Owner in Alector, Inc. ($ALEC) and Director in Alector, Inc. ($ALEC) and Director in Decibel Therapeutics, Inc. ($DBTX) and Director in NextCure, Inc. ($NXTC) and Director in LogicBio Therapeutics, Inc. ($LOGC) and Director in Silverback Therapeutics, Inc. ($SBTX) and Director in IMARA Inc. ($IMRA) and Director in Keros Therapeutics, Inc. ($KROS) and Director in Prelude Therapeutics Inc ($PRLD) and Director in PMV Pharmaceuticals, Inc. ($PMVP) and Director in ARMO BioSciences, Inc. ($ARMO) and Director in resTORbio, Inc. ($TORC) and Director in Prevail Therapeutics Inc. ($PRVL) and 10% Owner in SpringWorks Therapeutics, Inc. ($SWTX) and Director in Edgewise Therapeutics, Inc. ($EWTX) and Director in 89bio, Inc. ($ETNB) and Director in Arcutis Biotherapeutics, Inc. ($ARQT) and in Kinnate Biopharma Inc. ($KNTE) and Director in Oric Pharmaceuticals, Inc. ($ORIC) and Director in Repare Therapeutics Inc. ($RPTX) and Director in Fusion Pharmaceuticals Inc. ($FUSN) and Director in Terns Pharmaceuticals, Inc. ($TERN) and Director in Ikena Oncology, Inc. ($IKNA).
ORBIMED ADVISORS LLC in Sorrento Tech, Inc.
Trading Symbol: ROKAIndustry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of ORBIMED ADVISORS LLC: 10% Owner, Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 05 2017
$ROKA Market Capitalization: $8.04M
$ROKA Previous Close: $4.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ORBIMED ADVISORS LLC in Sorrento Tech, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ETNB, XLRN, AFIB, ADAP, TORC, AGLE, ARPO, ALEC, ALPN, ARQT, ARMO, BOLD, AVDR, CNST, CRVS, CTIC, DBTX, DMTX, EWTX, FUSN, GKOS, GRAY, GH, IKNA, IMRA, INSP, NTLA, ICPT, KALA, KROS, KNTE, LOGC, LOXO, NPCE, NXTC, ORIC, OTIC, PIRS, PMVP, PRLD, PRVL, PRNB, RLYP, RPTX, RPBIF, RYTM, SCPH, SELB, SIBN, SIEN, SRRA, SBTX, ROKA, SWTX, STDY, SYBX, THOR, TELA, TERN, TCDA, TPTX, VRAY, ASNS, XTNT
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 05 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 0.68 | 1,899 | 1,291 | 0 | 1.9 K to 0 (-100.00 %) |
Oct 05 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 0.68 | 199,718 | 135,808 | 0 | 199.7 K to 0 (-100.00 %) |
Oct 02 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 0.74 | 888 | 657 | 1,899 | 2.8 K to 1.9 K (-31.86 %) |
Oct 02 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 0.74 | 93,246 | 69,002 | 199,718 | 293 K to 199.7 K (-31.83 %) |
Oct 02 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 0.72 | 3,592 | 2,586 | 2,787 | 6.4 K to 2.8 K (-56.31 %) |
Oct 02 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 0.72 | 376,950 | 271,404 | 292,964 | 669.9 K to 293 K (-56.27 %) |
Sep 28 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 0.92 | 498 | 458 | 6,379 | 6.9 K to 6.4 K (-7.24 %) |
Sep 28 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 0.92 | 52,301 | 48,117 | 669,914 | 722.2 K to 669.9 K (-7.24 %) |
Sep 28 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.03 | 706 | 727 | 6,877 | 7.6 K to 6.9 K (-9.31 %) |
Sep 28 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.03 | 74,096 | 76,319 | 722,215 | 796.3 K to 722.2 K (-9.30 %) |
Aug 25 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.50 | 125 | 188 | 7,583 | 7.7 K to 7.6 K (-1.62 %) |
Aug 25 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.50 | 13,075 | 19,613 | 796,311 | 809.4 K to 796.3 K (-1.62 %) |
Aug 25 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.50 | 10 | 15 | 7,708 | 7.7 K to 7.7 K (-0.13 %) |
Aug 25 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.50 | 1,090 | 1,635 | 809,386 | 810.5 K to 809.4 K (-0.13 %) |
Aug 22 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.52 | 52 | 79 | 7,718 | 7.8 K to 7.7 K (-0.67 %) |
Aug 22 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.52 | 5,448 | 8,281 | 810,476 | 815.9 K to 810.5 K (-0.67 %) |
Aug 22 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.49 | 28 | 42 | 7,770 | 7.8 K to 7.8 K (-0.36 %) |
Aug 22 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.49 | 2,952 | 4,398 | 815,924 | 818.9 K to 815.9 K (-0.36 %) |
Aug 22 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.52 | 630 | 958 | 7,798 | 8.4 K to 7.8 K (-7.48 %) |
Aug 22 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.52 | 66,166 | 100,572 | 818,876 | 885 K to 818.9 K (-7.48 %) |
Sep 23 2016 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | Director | Option Exercise | P | 0.00 | 53,909 | 0 | 53,909 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | Director | Option Exercise | P | 0.00 | 5,660,377 | 0 | 5,660,377 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | Director | Option Exercise | P | 0.00 | 38 | 0 | 38 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | Director | Option Exercise | P | 0.00 | 3,962 | 0 | 3,962 |
Page: 1